The X-ray crystal structure of prethrombin2 (pre2), the immediate inactive precursor of a-thrombin, has been determined at 2.0 A resolution complexed with hirugen. The structure has been refined to a final R-value of 0.169 With the determination of isomorphous structures of hirugen-thrombin and D-Phe-Pro-Arg chloromethyl ketone (PPACK)-thrombin, the changes that occur in the active site that affect the kinetics of chromogenic substrate hydrolysis on binding to the fibrinogen recognition exosite have been determined. The backbone of the Ala 190-Gly 197 segment in the active site has an average RMS difference of 0.55 A between the 2 structures (about 3 . 7~ compared to the bulk structure). This segment has 2 type I1 0-bends, the first bend showing the largest shift due to hirugen binding. Another important feature was the 2 different conformations of the side chain of Glu 192.The side chain extends to solvent in hirugen-thrombin, which is compatible with the binding of substrates having a n acidic residue in the P 3 position (protein-C, thrombin platelet receptor). In PPACK-thrombin, the side chain of Asp 189 and the segment Arg 221A-Gly 223 move to provide space for the inhibitor, whereas in hirugenthrombin, the Ala 190-Gly 197 movement expands the active site region. Although 8 water molecules are expelled from the active site with PPACK binding, the inhibitor complex is resolvated with 5 other water molecules.
Keywords: activation; exosite binding; hirugen-thrombin; PPACK-thrombin; prethrombin2Prothrombin activation to a-thrombin by the prothrombinase complex (Factor Xa-Factor Va-phospholipids-Ca*+) initially proceeds through cleavage at Arg 320 (Arg 15, chymotrypsinogen numbering; Fig. 1) to give rise to the intermediate product meizothrombin (Krishnaswamy et al., 1987;Mann, 1987 Abbreviations: pre2, prethrombin2; Pre2 (with a capital), hirugenpre2 complex; PPACK, D-Phe-Pro-Arg chloromethyl ketone; Throm, or-thrombin; hirugen (Hir), hirudin 53-64; BPTI, bovine pancreatic trypsin inhibitor; DFP, di isopropylfluorophosphate; PEG, polyethyleneglycol; DAPA, dansyl-arginine N-(3-ethyl-1,5 pentanediy1)amide. This is followed by cleavage at Arg 271 to produce a-thrombin, which autolytically cleaves at Arg 284 to give a-thrombin (des Thr 272-Arg 284) (Downing et al., 1975). The stable form of athrombin is thus composed of the original residues from prothrombin Thr 285 to Arg 320, which corresponds to the A chain, and Ile 321 to Glu 579 in the B chain. In contrast, the activation of human prothrombin to a-thrombin by the catalyst Factor Xa-phospholipid-Ca'+ proceeds by cleavage at Arg 271 that leads to the noncovalently associated products, prothrombin fragment 1.2 (Ala 1-Arg 271) and pre2 (Thr 272-Glu 579). Subsequently, the catalytically inactive pre2 is cleaved at Arg 320 to a-thrombin and, ultimately, to the des Thr 272-Arg 284 cleavage product of a-thrombin. Thus, the simplest precursor form 2254